Given the current global pandemic of obesity and related diseases such as type 2 diabetes, and the lack of effective treatments, understanding the molecular mechanisms of hypothalamic insulin resistance is necessary for the development of safe and efficacious medications for the treatment of these metabolic disorders. This evidence concerns the gene INS and type 2 diabetes mellitus.